AstraZeneca Group plc


AstraZeneca Inks $486M US Support For Covid-19 Antibody Cocktail

AstraZeneca has secured $486m from the US Government for the development and supply of 100,000 doses of its potential AZD7442 antibody cocktail for …

Dr. Reddy’s Laboratories (RDY) has announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe.

AstraZeneca’s Wins FDA Priority Review For Heart Drug Brilinta

AstraZeneca Plc (AZN) announced on Thursday that the Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted …

AstraZeneca-Merck Pancreatic Cancer Drug Wins European Approval

AstraZeneca Plc’s (AZN) and Merck Co.’s (MRK) Lynparza drug has received a green light from the European Commission (EC) for the treatment of …

AstraZeneca Strikes $127 Million Deal With Brazil For Covid-19 Vaccine

AstraZeneca Plc (AZN) has signed a $127 million deal with Brazil for the production of its potential COVID-19 vaccine. Under the terms of …

Oxford Biomedica Clinches Manufacturing Deal For AstraZeneca’s Covid-19 Vaccine

Oxford Biomedica (OXBDF) has signed a five-year collaboration agreement with UK’s Vaccines Manufacturing and Innovation Centre (VMIC), to help ramp up the production …

AstraZeneca Approached Gilead For Potential Merger – Report

UK-based pharmaceutical company AstraZeneca Plc (AZN) is reportedly interested in a potential merger with rival drugmaker Gilead Sciences Inc. (GILD) in what would …

AstraZeneca Seeks To Make 2 Billion Covid-19 Vaccine Doses With New Supply Deals

UK-based pharmaceutical company AstraZeneca Plc (AZN) announced on Thursday that it has signed supply deals for the capacity to produce 2 billion doses …

AstraZeneca Partners With Accent To Develop Novel Cancer Treatments

UK-based pharmaceutical company AstraZeneca Plc (AZN) on Thursday announced a collaboration with Accent Therapeutics to develop targeting RNA-modifying proteins (RMPs) for the treatment of …

5 Promising Covid-19 Vaccines Now Selected For Trump’s Operation Warp Speed

Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts